Growth Metrics

BioNTech SE (BNTX) EPS (Weighted Average and Diluted) (2023 - 2024)

BioNTech SE's EPS (Weighted Average and Diluted) history spans 2 years, with the latest figure at $144972.1 for Q4 2024.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 21.26% to $144972.1 in Q4 2024 year-over-year; TTM through Dec 2024 was $144972.1, a 21.26% increase, with the full-year FY2024 number at -$2.96, down 171.83% from a year prior.
  • EPS (Weighted Average and Diluted) hit $144972.1 in Q4 2024 for BioNTech SE, down from $147284.0 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for BNTX hit a ceiling of $151649.5 in Q3 2023 and a floor of $119556.1 in Q4 2023.